iiinova — where your digital self keeps evolving

Reposted by ELPA

GENIAL Horizon Europe @genial-project.bsky.social · 19/06/2026

🎗️ GENIAL and its partner projects are helping shape a more equitable future for cancer prevention, research, and care across Europe through the EU Mission Cancer initiative. #GENIALProject #EUMissionCancer #CancerResearch #HealthEquity

032

ELPA @europeliver.bsky.social · 11/06/2026

🌍💛 GLOBAL FATTY LIVER DAY Today, the #EuropeanLiverScreeningTour by ELPA in Münster, bringing liver health directly to the people through screening activities at two locations across the city. .

021

Reposted by ELPA

Nina Donner @ninadonner.bsky.social · 01/06/2026

Back home from an inspiring & energising #EASLCongress in sunny + hot Barcelona 🌅. These were my personal highlights (sound on 🔊) - what were your‘s? 😎 #Barcelona #EASL2026 #LiverDisease #LiverHealth #ACLF @europeliver.bsky.social @medblab.bsky.social @horizoneu.bsky.social @easlnews.bsky.social

094

Reposted by ELPA

ELPA @europeliver.bsky.social · 20/05/2026

Why ELPA is going on a unique European Liver Screening Tour ELPA is going on a unique European Liver Screening Tour because Europe can no longer afford to wait for liver disease to become visible only when it is already advanced. For too long, liver disease has remained silent.

075

Reposted by ELPA

DECISION Horizon2020 @decision4liver.bsky.social · 27/05/2026

In the co-session 'Patient/provider communication', @korenjak.bsky.social (president of @europeliver.bsky.social) stresses three vital in this communication relationship: ⏳ Time 📍Point-of-view 💬Miscommunication @microb-predict.bsky.social @a-tango.bsky.social #EASL2026 #EASLCongress

085

Reposted by ELPA

MICROB-PREDICT @microb-predict.bsky.social · 27/05/2026

It's always great to meet the consortium's #PatientRepresentatives (from European Liver Patients' Association - ELPA) in person - this year in sunny (and hot ⛱️🌞😎) Barcelona, Spain, for #EASLCongress! @medblab.bsky.social @easlnews.bsky.social @horizoneu.bsky.social @europeliver.bsky.social

074

Reposted by ELPA

MICROB-PREDICT @microb-predict.bsky.social · 30/05/2026

💊 Non-selective #betablocker use was associated with improved survival across all stages of chronic #LiverDisease, including pre-ACLF & #ACLF: 👏 #POSTER SAT-458-YI by Josune Cabello Calleja et al. #EASL2026 #Cirrhosis #Hepatology @medblab.bsky.social @easlnews.bsky.social @europeliver.bsky.social

073

Reposted by ELPA

MICROB-PREDICT @microb-predict.bsky.social · 30/05/2026

💪 Strong finish of #EASL2026 with ✨ Highlights from the MICROB-PREDICT Consensus Conference ✨ at our #Networking session - Thanks for coming 🤗! #Microbiome-based #mechanisms #biomarkers #PatientStratification #cirrhosis #ACLF @medblab.bsky.social @easlnews.bsky.social @europeliver.bsky.social

083

Reposted by ELPA

MICROB-PREDICT @microb-predict.bsky.social · 30/05/2026

🧬 Rocking the presentation of two posters at #EASLCongress 2026 - wow 🤩! 👏 Sania Arif did a great job at these posters today. #ACLF #Cirrhosis #Metabolomics #BacterialInfection #Hepatology #SystemicInflammation #Microbiome @medblab.bsky.social @easlnews.bsky.social @europeliver.bsky.social

062

Reposted by ELPA

MICROB-PREDICT @microb-predict.bsky.social · 30/05/2026

👏 Two posters by David Tornai today at #EASLCongress! #POSTER SAT-414-YI explored the prognostic value of serum secretory #IgA in patients with #PSC. #POSTER SAT-415 evaluated circulating #macrophage activation markers as prognostic tools in #PSC. @easlnews.bsky.social @europeliver.bsky.social

073

Reposted by ELPA

MICROB-PREDICT @microb-predict.bsky.social · 30/05/2026

😁 Those two had fun at their #Poster: Congratulations to Philipp Althaus & Sabine Klein together with other colleagues from the MedB Lab (Münster, Germany), on this excellent poster presentation at #EASLCongress 2026 this Saturday! @medblab.bsky.social @easlnews.bsky.social @europeliver.bsky.social

183

Reposted by ELPA

A-TANGO Project @a-tango.bsky.social · 31/05/2026

💫 Three outstanding Charité posters at #EASLCongress 2026 in Barcelona - well done, Sina, Joscha & Alex! 1️⃣ Body composition & survival in HRS-AKI 2️⃣ Macrophages & gut barrier failure in alcoholic hepatitis🍷 3️⃣ Thrombin generation🩸in #cirrhosis & #ACLF @easlnews.bsky.social @europeliver.bsky.social

073

Reposted by ELPA

Artemis-euproject @artemis-euproject.bsky.social · 30/05/2026

📍 #EASLCongress2026 The ARTEMIS EU Project was proudly presented to ELPA members ELPA-organized event featured outstanding presentations, from Prof. Irene Vignon-Clementel (Inria), Dr. Raluca Pais (Pitié-Salpêtrière Hospital, Paris), and Prof. Juan Manuel Pericàs (Vall d'Hebron University Hospital

042

Reposted by ELPA

MICROB-PREDICT @microb-predict.bsky.social · 28/05/2026

🤩 What a comprehensive, interactive and fun afternoon session 🧬 at #EASLCogress today: More than 100 attendees, compelling evidence & a majority of agreement on 26 of 31 Delphi statements from a recently completed consensus survey! @medblab.bsky.social @easlnews.bsky.social @europeliver.bsky.social

083

Reposted by ELPA

A-TANGO Project @a-tango.bsky.social · 28/05/2026

🧠 The modified hepatic encephalopathy staging tool (mHEST) outperformed West Haven criteria in diagnostic consistency and prognostic performance. #POSTER TOP-471-YI by Annarein Kerbert et al. #EASL2026 #HepaticEncephalopathy #Cirrhosis #Hepatology @rajivjalan.bsky.social @europeliver.bsky.social

083

Reposted by ELPA

MICROB-PREDICT @microb-predict.bsky.social · 28/05/2026

Moritz Marciniak (Münster, Germany) at his #poster yesterday! 🤩 Young stars in the making 👉 POSTER ID WED-307 RNA - based #CRISPR/Cas9 - mediated genetic modification of the copper transporter ATP7B in #WilsonDisease @medblab.bsky.social @europeliver.bsky.social @easlnews.bsky.social

083

Reposted by ELPA

MICROB-PREDICT @microb-predict.bsky.social · 28/05/2026

📢 This morning at #EASLCongress in Barcelona, EASL Secretary General Debbie Shawcross (King's College London) co-chaired the "General Session I and #AwardCeremony" 🏆! @easlnews.bsky.social @europeliver.bsky.social @kingscollegelondon.bsky.social @debbieshawcross.bsky.social #GeneralHepatology

073

Reposted by ELPA

United European Gastroenterology @myueg.bsky.social · 28/05/2026

Patient voices must sit at the heart of digestive health strategy 💬 Our manifesto outlines actions to drive meaningful change across: Digestive cancer care 🎗️ Patient-reported outcomes (PROMs) 📊 Patient involvement in clinical trials 🧪 Learn more 👉 ueg.eu/a/380

A group of adults, some in professional attire, gathered together in an indoor setting with signs and branding related to the United European Gastroenterology organization.

142

Reposted by ELPA

MICROB-PREDICT @microb-predict.bsky.social · 28/05/2026

💡Co-chaired by Maria Papp (Debrecen, Hungary), this was a key session at #EASLCongress today on acute #encephalopathy in #cirrhosis and the challenges of recognising hepatic encephalopathy (HE) versus other causes of altered mental status in the ICU. @easlnews.bsky.social @europeliver.bsky.social

173

Reposted by ELPA

MICROB-PREDICT @microb-predict.bsky.social · 28/05/2026

🧬 Reduced #apoptosis in HBV/HDV-expressing #hepatocytes: Poster THU-595 by @Pia Lembeck et al. investigated how HDV modulates apoptotic + #StressResponse pathways in HBV/HDV-expressing hepatocytes. 📍Presented at #EASLCongress 2026 @medblab.bsky.social @easlnews.bsky.social @europeliver.bsky.social

173

Reposted by ELPA

MICROB-PREDICT @microb-predict.bsky.social · 28/05/2026

📊 More inclusive definitions of non-acute decompensation #NAD to improve #RiskStratification in chronic #LiverDisease. ✨ POSTER WED-485 by Martin S. McCoy et al. was featured in today's #PosterTour! #EASLCongress #Cirrhosis @medblab.bsky.social @easlnews.bsky.social @europeliver.bsky.social

073

Reposted by ELPA

A-TANGO Project @a-tango.bsky.social · 28/05/2026

🧬 Novel #biomarker composites may help predict #AKI and #mortality following acute decompensation of #cirrhosis. 📍Presented in #POSTER WED-448-YI by Olivia Greenham et al. during #EASLCongress 2026! #RiskStratification #LiverDisease #Patients @europeliver.bsky.social @rajivjalan.bsky.social

082

Reposted by ELPA

MICROB-PREDICT @microb-predict.bsky.social · 28/05/2026

🚨 Michael Praktiknjo et al. validated a custom-built 22G #EUS-PPG system with great correlation to the commercial 25G platform. 👉 Lower cost💲+ better availability may expand access to #PortalHypertension assessment worldwide 🌎! @medblab.bsky.social @europeliver.bsky.social @easlnews.bsky.social

063

Reposted by ELPA

MICROB-PREDICT @microb-predict.bsky.social · 29/05/2026

📊 A nationwide German study highlights changing trends in hepatocellular carcinoma severity, treatment strategies & complications 2005-2019: #POSTER FRI-220 by Josune Cabello Calleja et al. #EASL2026 #HCC #LiverCancer #Hepatology @medblab.bsky.social @easlnews.bsky.social @europeliver.bsky.social

063

Reposted by ELPA

MICROB-PREDICT @microb-predict.bsky.social · 29/05/2026

🧬 Maladaptive emergency #myelopoiesis may drive progression from acutely decompensated cirrhosis to ACLF. 👉 #POSTER FRI-388-YI by Zhujun Cao et al. #EASLCongress #EASL2026 #ACLF #Cirrhosis #Immunology #DecompensatedCirrhosis @medblab.bsky.social @europeliver.bsky.social @easlnews.bsky.social

053

Reposted by ELPA

MICROB-PREDICT @microb-predict.bsky.social · 29/05/2026

🧬 Impaired endothelial FoxO1 signalling may contribute to endothelial dysfunction in ACLF. 👉 #POSTER FRI-428-YI by Fabian Schachteli et al. #EASL2026 #EASLCongress #ACLF #Cirrhosis #Hepatology @medblab.bsky.social @easlnews.bsky.social @europeliver.bsky.social

153

Reposted by ELPA

MICROB-PREDICT @microb-predict.bsky.social · 29/05/2026

✨ Poster Tour Highlight ✨ 🩺 Reductions in phosphatidylethanol #PEth are associated with improvements in #BloodPressure & lipid profile in steatotic liver disease #SLD. Shown by Nikolaj Torp et al. in #POSTER THU-204. #EASL2026 #SLD #MASLD #Hepatology @easlnews.bsky.social @europeliver.bsky.social

053

Reposted by ELPA

MICROB-PREDICT @microb-predict.bsky.social · 29/05/2026

👏 Minneke Coenraad's group (LUMC) has a strong presence during today's #PosterSession at #EASLCongress! See below what they investigated by watching our short movie clip 🎬... #Hepatology #LiverTransplantation #MELD #Cirrhosis @easlnews.bsky.social @europeliver.bsky.social @unileiden.bsky.social

053

Reposted by ELPA

MICROB-PREDICT @microb-predict.bsky.social · 30/05/2026

Today at #EASLCongress 2026 🎤: Thesession "EASL / EF-CLIF: The Road Ahead – Horizon Scanning in #Cirrhosis & #PortalHypertension" spotlighted the next wave of evidence that could reshape the management of advanced #LiverDisease! @europeliver.bsky.social @easlnews.bsky.social @medblab.bsky.social

153

Reposted by ELPA

A-TANGO Project @a-tango.bsky.social · 23/05/2026

🥳 Join the A-TANGO Networking Session at #EASLCongress! 🗓 Fri, 29 May 2026 ⏰ 10:00–10:30 📍 Cirrhosis & Complications Track Hub 6 The A-TANGO Score: A Novel Tool for Risk Stratification & #ClinicalEndpoints in #ACLF @rajivjalan.bsky.social @easlnews.bsky.social @europeliver.bsky.social

054

Reposted by ELPA

A-TANGO Project @a-tango.bsky.social · 23/05/2026

📣 SNEAK PEEK 🔍 of posters, talks, networking sessions & chairing activities by Consortium Members during #EASLCongress next week (27-30 May 2026) in Barcelona! #ACLF #cirrhosis #LiverDisease #LiverFailure #Hepatology #LiverSky @rajivjalan.bsky.social @europeliver.bsky.social @easlnews.bsky.social

053

Reposted by ELPA

MICROB-PREDICT @microb-predict.bsky.social · 23/05/2026

Excited about a strong MICROB-PREDICT presence at #EASL2026! 🌍🦠 4 days of in-depth sessions, posters & networking on #cirrhosis, #ACLF, #microbiome, #biomarkers & precision #hepatology - capped by the Networking Session on Sat! @medblab.bsky.social @europeliver.bsky.social @easlnews.bsky.social

073

ELPA @europeliver.bsky.social · 20/05/2026

075

ELPA @europeliver.bsky.social · 19/05/2026

#Hepatitis B, C and D are not just #infectious diseases. They are among the leading causes of #livercancer in Europe.

131

ELPA @europeliver.bsky.social · 19/05/2026

A proud milestone for patient engagement in liver health ELPA, we are deeply proud that the ICONIC Project has been selected as a finalist for the Patient Engagement Award 2026 This recognition is more than an achievement

031

ELPA @europeliver.bsky.social · 11/05/2026

🇨🇾🇪🇺 European Liver Screening Tour 2026 – Cyprus Liver disease increases the risk of cardiovascular disease, stroke, diabetes, and cancer. 🔹 MASLD & MASH 🔹 Hepatitis & Liver Cancer 🔹 Cardiovascular Disease & Stroke 🔹 Alcohol-related Liver Disease 🔹 Rare Liver Diseases 🔹 Transplantation

031

Reposted by ELPA

LIVERAIM @liveraim.bsky.social · 19/04/2026

🌍 #WorldLiverDay 2026: Solid habits, strong liver #cgronicliverdiseases are often silent, but largely preventable! 💪 Healthy habits + 🔍 early detection matter. #LIVERAIM is working for making #earlydiagnosis reality! @ihieurope.bsky.social @easlnews.bsky.social @europeliver.bsky.social

162

Reposted by ELPA

United European Gastroenterology @myueg.bsky.social · 07/05/2026

🔎 A closer look at Europe’s cancer statistics reveals a clear reality: digestive cancers account for a significant share of deaths. Our latest position paper outlines the actions needed to strengthen screening 👉 bit.ly/4mYFleR

The image provides information on digestive cancers and their cancer-related mortality rates in the European Union for 2022, including statistics for gastric cancer, liver cancer, colorectal cancer, and pancreatic cancer.

152

ELPA @europeliver.bsky.social · 02/05/2026

#Prevention is power. Protection is possible. Lives can be saved. 💙 💉 Vaccination is not just healthcare—it’s hope. 💪 Together, we can reduce suffering and save lives. #WorldImmunisationWeek #HepatitisB #VaccinesWork #PreventCancer #LiverCancer #HealthForAll #HBV

030

Reposted by ELPA

DECISION Horizon2020 @decision4liver.bsky.social · 23/04/2026

Why do some cirrhosis patients suddenly deteriorate? #DNAmethylation changes are linked to worse outcomes in acute decompensation, pointing to a key role of #epigenetic regulation in disease progression. 🎥 Watch the explainer: youtu.be/yzTTzx68Sq8 @europeliver.bsky.social

063

Reposted by ELPA

MICROB-PREDICT @microb-predict.bsky.social · 16/04/2026

🚨Take this 15 min survey to shape the future of #Hepatology: 👉 survey.alchemer.eu/s3/91085482/... 🦠 #Microbiome-based mechanisms & biomarkers for improved patient stratification + prediction of therapeutic response in decompensated #Cirrhosis / #ACLF ⏳Survey closes on 17 May @easlnews.bsky.social

194

Reposted by ELPA

GENIAL Horizon Europe @genial-project.bsky.social · 19/04/2026

#WorldLiverDay Preventing liver cancer starts with healthy habits. Through the GENIAL project, a European research consortium funded by the Horizon Europe programme, we are working to identify the environmental and genetic factors that predispose individuals to alcohol-related liver cancer

041

Reposted by ELPA

GENIAL Horizon Europe @genial-project.bsky.social · 17/07/2025

🌍 The #GENIALproject unites 14 institutions from 7 European countries to tackle alcohol-related liver cancer with cutting-edge research and AI. Funded by #HorizonEurope, we work together for innovation and equity in cancer care. 🔗Learn more: genial-project.com #EUScience #HealthInnovation

053

Reposted by ELPA

ELPA @europeliver.bsky.social · 18/04/2025

“Microb-Predict is the best example of patient-centered research.” On #WorldLiverDay, we celebrate science that cares. Let’s keep fighting for the most vulnerable liver patients. #MicrobPredict #LiverHealth #ELPA #HorizonEU #PatientsFirst @microb-predict.bsky.social @decision4liver.bsky.social

082